Iga Swiatek Accepts One-Month Suspension for Doping Violation
Tennis champion Iga Swiatek faces a one-month ban after testing positive for trimetazidine, linked to her melatonin use due to jet lag.
Subscribe to unlock this story
We really don't like cutting you off, but you've reached your monthly limit. At just $3/month or $30/year, subscriptions are how we keep this project going. Start your free 7-day trial today!
Get StartedNo highlights available for this story.
Summary
Iga Swiatek, the world No. 2 tennis player, has accepted a one-month suspension after testing positive for banned substance trimetazidine. The International Tennis Integrity Agency ruled that the positive test was unintentional and due to contamination from melatonin, a nonprescription medication she used for jet lag. Swiatek's suspension commenced after she missed three tournaments earlier. In total, she forfeits prize money from her Cincinnati Open performance as part of her penalty. The case highlights ongoing challenges athletes face regarding medication safety in competitive environments.
Perspectives
No center-leaning sources available for this story.